READ: New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care

Prime Therapeutics/Magellan Rx Management (Prime/MRx) researchers Brooke Hunter, MS, senior health outcomes scientist, Kristin Brown-Gentry, MS, director of clinical outcomes and analytics, Mark Santilli, PharmD, senior director of clinical strategy and programs and Karim Prasla, PharmD, MS, BCPS, vice president of clinical outcomes, analytics, and research, examine a study that was recently published in the Journal of Managed Care & Specialty Pharmacy. Read the full publication.